TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15486408

Group type: EXPERIMENTAL
Intervention: Sitaxsentan (100 mg/d)
Number of subjects: 11
Study: 11712824

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 19
Study: 9547423

Group type: EXPERIMENTAL
Intervention: Self-reward instructions and materials delivered at the end of the BSE training session
Number of subjects: 1649

Group type: EXPERIMENTAL
Intervention: Self-reward suggestions delivered through the mail each month, contingent upon BSE performance
Number of subjects: 1649

Group type: EXPERIMENTAL
Intervention: External monetary rewards and self-reward suggestions delivered through the mail each month on an intermittent schedule, contingent upon BSE practice
Number of subjects: 1649

Group type: COMPARATOR
Intervention: No-reward control condition
Number of subjects: 1649
Study: 8042812

Group type: EXPERIMENTAL
Intervention: Oropharyngeal classification (OP class) assessment with various method combinations (sitting, head in extension, tongue out, with/without phonation)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Mandibular space (MS) length measurement with various method combinations (sitting, head in extension, distance from inside of mentum to thyroid cartilage)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Combined performance index of OP class and MS length
Number of subjects: 213
Study: 3195433

Group type: EXPERIMENTAL
Intervention: History of cigarette smoking within 6 months
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Time from onset of symptoms to peak CK‐MB value
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Congestive heart failure during or after hospitalization
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Mortality during hospitalization or follow-up
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Ejection fractions on radionuclide ventriculography at 10 days and 3 months after AMI
Number of subjects: 328
Study: 30041587

Group type: EXPERIMENTAL
Intervention: Mutual-access EHRs
Number of subjects: 141

Group type: COMPARATOR
Intervention: No mutual-access EHRs
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Overall communication
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Mental health hospitalizations and emergency department visits
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Medications acknowledged in PCP record
Number of subjects: 141
Study: 26643401

Group type: EXPERIMENTAL
Intervention: COMBEX (community-based exercise program)
Number of subjects: 34

Group type: COMPARATOR
Intervention: EX (outpatient exercise program at the hospital)
Number of subjects: 34
Study: 25899562

Group type: EXPERIMENTAL
Intervention: ALA-PDT + CO2 laser
Number of subjects: 18

Group type: COMPARATOR
Intervention: CO2 laser alone
Number of subjects: 18
Study: 23824974

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 0
Study: 21126127

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg plus low dose aspirin (LDA), n = 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enoxaparin 20 mg plus LDA, n = 30
Number of subjects: 60
Study: 18565233

Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg once a day
Number of subjects: 3011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3011
Study: 16497101

Group type: EXPERIMENTAL
Intervention: Goeckerman's therapy (GT) including dermal application of crude coal tar and exposure to UV radiation
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Goeckerman's therapy (GT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Patients before GT
Number of subjects: 56
Study: 14571257

Group type: EXPERIMENTAL
Intervention: Oral D-amphetamine (AMPH) 30 mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 11483804

Group type: EXPERIMENTAL
Intervention: AeroChamber mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hans Rudolph mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: NebuChamber mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BabyHaler mask
Number of subjects: 30

Group type: COMPARATOR
Intervention: Uncoached session
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Coached session
Number of subjects: 30
Study: 9894373

Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil (adjustable to 100 mg or 25 mg based on efficacy and tolerability)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil
Number of subjects: 329
Study: 8114658

Group type: EXPERIMENTAL
Intervention: Kangaroo care (KC) for 2 to 3 hours
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (pretest/posttest design)
Number of subjects: 31
Study: 3281463

Group type: EXPERIMENTAL
Intervention: Cefotetan 1 to 2 gm every 12 hours
Number of subjects: 188

Group type: COMPARATOR
Intervention: Cefoxitin 1 to 2 gm every 6 hours
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 188

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 188
Study: 30083968

Group type: EXPERIMENTAL
Intervention: Modified Broström procedure with calcaneofibular ligament (CFL) repair
Number of subjects: 50

Group type: COMPARATOR
Intervention: Modified Broström procedure without CFL repair (ATFL only group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (CFL and ATFL only)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CFL repair
Number of subjects: 50
Study: 31290573

Group type: EXPERIMENTAL
Intervention: Cryopreserved PLTs
Number of subjects: 121

Group type: COMPARATOR
Intervention: Liquid-stored PLTs
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 121
Study: 28542176

Group type: COMPARATOR
Intervention: DHS-style survey variant (little contextual detail about the wife's intentions)
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: Survey variant depicting the wife as intentionally violating gendered standards of behavior
Number of subjects: 1334

Group type: EXPERIMENTAL
Intervention: Survey variant depicting the wife as unintentionally violating gendered standards of behavior
Number of subjects: 1334

Group type: COMPARATOR
Intervention: DHS-style survey variant (control)
Number of subjects: 1334
Study: 25431336

Group type: EXPERIMENTAL
Intervention: Rolofylline
Number of subjects: 2033

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2033
Study: 22495503

Group type: EXPERIMENTAL
Intervention: WebChoice
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (URLs of publicly available cancer websites)
Number of subjects: 325
Study: 22211208

Group type: EXPERIMENTAL
Intervention: Web-based intervention featuring actors simulating a patient discussing treatment concerns (N=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group shown an educational video about schizophrenia treatment (N=26)
Number of subjects: 50
Study: 19921623

Group type: EXPERIMENTAL
Intervention: Clobazam (CLB)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 38
Study: 16802845

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (SMART)
Number of subjects: 2143

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone (SFC)
Number of subjects: 2143
Study: 12539209

Group type: EXPERIMENTAL
Intervention: Thalamic deep brain stimulation (DBS)
Number of subjects: 39
Study: 10694624

Group type: EXPERIMENTAL
Intervention: Intermediate lukewarm (20 degrees C) cardioplegia
Number of subjects: 135

Group type: COMPARATOR
Intervention: Cold (8 degrees C) cardioplegia
Number of subjects: 135

Group type: COMPARATOR
Intervention: Warm (37 degrees C) cardioplegia
Number of subjects: 135
Study: 9381445

Group type: EXPERIMENTAL
Intervention: Letter arguing for reduction of daily benzodiazepine intake
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no letter)
Number of subjects: 169
Study: 8410962

Group type: EXPERIMENTAL
Intervention: alprazolam (1 mg) and alcohol (0.5 g/kg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: alprazolam (1 mg) and placebo drink
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: placebo capsule and alcohol (0.5 g/kg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo capsule and placebo drink
Number of subjects: 48
Study: 3101616

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cow's milk formula (untreated)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cow's milk formula (treated with lactase)
Number of subjects: 10
Study: 31096953

Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ultrasonographic osteophyte score
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ultrasonographic erosion
Number of subjects: 93
Study: 27864822

Group type: EXPERIMENTAL
Intervention: Home‐based hand‐arm bimanual intensive therapy (H‐HABIT; n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lower‐limb functional intensive training (LIFT-control; n=12)
Number of subjects: 24
Study: 25041071

Group type: EXPERIMENTAL
Intervention: DECISION+2 (two-hour online tutorial, two-hour workshop, and decision support tools)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: DECISION+2
Number of subjects: 359
Study: 24669687

Group type: EXPERIMENTAL
Intervention: Surgery plus radiotherapy (S+R group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 59
Study: 21219602

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507
Study: 19324530

Group type: EXPERIMENTAL
Intervention: oxcarbazepine (1,000‐2,400 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: divalproex (750‐2,000 mg/day)
Number of subjects: 60
Study: 17684201

Group type: EXPERIMENTAL
Intervention: DHA oil (7.5 g DHA oil/d, equivalent to 3 g DHA/d)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 34
Study: 15113640

Group type: EXPERIMENTAL
Intervention: Bidding game format
Number of subjects: 106

Group type: COMPARATOR
Intervention: Open-ended format
Number of subjects: 106

Group type: COMPARATOR
Intervention: Payment scale format
Number of subjects: 106
Study: 11719729

Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Racemic ketamine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: R(‐)‐ketamine
Number of subjects: 10
Study: 10088202

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg once a day for 4 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Metoprolol 95 mg once a day for 4 weeks
Number of subjects: 9
Study: 7529981

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day prednisolone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 5.0 mg/day prednisolone
Number of subjects: 10
Study: 2977271

Group type: EXPERIMENTAL
Intervention: Long-acting D-Trp-6 LH-RH
Number of subjects: 113
Study: 30704025

Group type: EXPERIMENTAL
Intervention: KiVa anti-bullying program (n = 536)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Control condition (n = 516)
Number of subjects: 1051
Study: 29141124

Group type: EXPERIMENTAL
Intervention: Valbenazine 80 mg
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Valbenazine 40 mg
Number of subjects: 198

Group type: COMPARATOR
Intervention: Placebo (during initial 6-week period)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Overall Valbenazine treatment
Number of subjects: 198
Study: 25660012

Group type: EXPERIMENTAL
Intervention: Krakow stitch (KS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Simple suture (SS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lasso loop (LL)
Number of subjects: 18
Study: 23374797

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 μg/kg/min for 24 hours)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 21200340

Group type: EXPERIMENTAL
Intervention: Trained FDI's MVC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Untrained FDI's MVC
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Corticospinal excitability in iM1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Interhemispheric inhibition
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonexercising control group
Number of subjects: 12
Study: 19650803

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FIC) with 30 ml of ropivacaine 3.75 mg/ml (112.5 mg) 20 min before spinal block
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FIC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous analgesia with alfentanil (IVA) - bolus dose of 10 microg/kg, continuous infusion of 0.25 microg/kg/min starting 2 min before spinal block
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous analgesia with alfentanil (IVA)
Number of subjects: 40
Study: 17669280

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omission of radiotherapy
Number of subjects: 0
Study: 15209007

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Once weekly iron supplementation
Number of subjects: 353

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 353
Study: 14512036

Group type: EXPERIMENTAL
Intervention: Diet designed for patients with diabetes (DD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fibre-enriched diet (FD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard diets (SD and FD)
Number of subjects: 11
Study: 9971864

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfusions if hemoglobin < 7.0 g/dL, maintained at 7.0 to 9.0 g/dL)
Number of subjects: 838

Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusions if hemoglobin < 10.0 g/dL, maintained at 10.0 to 12.0 g/dL)
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 838

Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 838
Study: 7573591

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supportive psychotherapy
Number of subjects: 32
Study: 2099731

Group type: EXPERIMENTAL
Intervention: Mucaine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mucaine without oxethazaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 6932992

Group type: EXPERIMENTAL
Intervention: BCG and monthly chemotherapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Weekly irradiated allogeneic blast cells
Number of subjects: 86

Group type: COMPARATOR
Intervention: Not achieving complete remission
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Patients alive without relapse
Number of subjects: 86
Study: 31156155

Group type: EXPERIMENTAL
Intervention: Regular + NPH Insulin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Novo‐rapid + Levemir Insulin
Number of subjects: 100
Study: 28973074

Group type: EXPERIMENTAL
Intervention: SAbR plus maintenance chemotherapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Maintenance chemotherapy alone
Number of subjects: 29
Study: 27143035

Group type: EXPERIMENTAL
Intervention: Higher BMI groups
Number of subjects: 1664

Group type: COMPARATOR
Intervention: Low BMI/High fitness group
Number of subjects: 1664

Group type: EXPERIMENTAL
Intervention: Fitness
Number of subjects: 1664

Group type: EXPERIMENTAL
Intervention: Obese girls
Number of subjects: 1664

Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 1664

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 1664

Group type: EXPERIMENTAL
Intervention: LP-IR
Number of subjects: 1664
Study: 24290148

Group type: EXPERIMENTAL
Intervention: Four double-page questionnaire
Number of subjects: 2269

Group type: COMPARATOR
Intervention: Two double-page questionnaire
Number of subjects: 2269

Group type: EXPERIMENTAL
Intervention: One double-page questionnaire
Number of subjects: 2269
Study: 22858181

Group type: EXPERIMENTAL
Intervention: Ambrisentan
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study: 20223094

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1000 mg/day)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 17561969

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasonography
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy (EIS)
Number of subjects: 44
Study: 15770383

Group type: EXPERIMENTAL
Intervention: Lateral internal sphincterotomy in addition to Milligan‐Morgan hemorrhoidectomy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Milligan‐Morgan hemorrhoidectomy alone
Number of subjects: 78
Study: 12222646

Group type: EXPERIMENTAL
Intervention: True interference group (artificial interferences introduced)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo interference group (simulated interferences)
Number of subjects: 47
Study: 10223757

Group type: EXPERIMENTAL
Intervention: Local anesthetic injection (1 to 2 ml of 2 percent lignocaine) during triple rubber band ligation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no local anesthetic injection) during triple rubber band ligation
Number of subjects: 101
Study: 8847153

Group type: EXPERIMENTAL
Intervention: Brodimoprim 400 mg OD on the first day followed by 200 mg OD for 2 days
Number of subjects: 203

Group type: COMPARATOR
Intervention: Norfloxacin 400 mg BID
Number of subjects: 203
Study: 29533540

Group type: EXPERIMENTAL
Intervention: Modified Misgav‐Ladach method (MML)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Pfannenstiel-Kerr method (PK)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 252
Study: 28534476

Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS) management
Number of subjects: 350

Group type: COMPARATOR
Intervention: Conventional directly observed therapy (DOT)
Number of subjects: 350
Study: 26448482

Group type: EXPERIMENTAL
Intervention: Parental concerns about treatment efficacy and side effects
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Parental concerns about child health
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Parental concerns about psychosocial function
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Parental education and parenting style
Number of subjects: 1820
Study: 23222075

Group type: EXPERIMENTAL
Intervention: Ballistic Bench Press (BBP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of BBP and HRT
Number of subjects: 20
Study: 21359598

Group type: EXPERIMENTAL
Intervention: Ezetimibe monotherapy 10 mg/day (EZT group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Therapeutic lifestyle changes (TLC group)
Number of subjects: 60
Study: 18554825

Group type: EXPERIMENTAL
Intervention: Participant-partner psychological aggression
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Participant-partner physical aggression
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Participant-partner injury
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Partner-to-participant psychological aggression
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Partner-to-participant physical aggression
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Partner-to-participant injury
Number of subjects: 489
Study: 16860035

Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy with human recombinant alpha‐L‐iduronidase
Number of subjects: 5
Study: 12884356

Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging (DWI) with a modified pulse sequence and breath holding, using five different b gradient factor values (50 to 250 s/mm(2)).
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control subjects (no specific intervention mentioned).
Number of subjects: 28
Study: 10844053

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily) and nicotinamide (300 mg daily) for 3 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9093632

Group type: EXPERIMENTAL
Intervention: Chloroquine-Chlorpheniramine combination
Number of subjects: 112

Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 112
Study: 3545785

Group type: EXPERIMENTAL
Intervention: Tetrabamate (three 300 mg tablets/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Tetrabamate
Number of subjects: 68
Study: 21255807

Group type: EXPERIMENTAL
Intervention: α-lipoic acid 600 mg via intravenous infusion once a day for 3 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Untreated experimental group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 60
Study: 29931320

Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 20 mg/d
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 40 mg/d
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 60 mg/d
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 27837656

Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to negative feedback)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to positive feedback)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Experimental group (general findings)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Experimental group (vulnerable children)
Number of subjects: 190
Study: 25533727

Group type: EXPERIMENTAL
Intervention: Daily weight tracking
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Weekly weight tracking
Number of subjects: 339

Group type: COMPARATOR
Intervention: No weight tracking
Number of subjects: 339
Study: 23869537

Group type: EXPERIMENTAL
Intervention: Human-derived milk fortifier (HDMF)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Maternal human milk (MHM)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Early preterm maternal human milk (MHM)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Donor human milk (DHM)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Early maternal human milk (MHM)
Number of subjects: 164